Asleh, R.; Vucicevic, D.; Petterson, T.M.; Kremers, W.K.; Pereira, N.L.; Daly, R.C.; Edwards, B.S.; Steidley, D.E.; Scott, R.L.; Kushwaha, S.S.
Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study. J. Clin. Med. 2022, 11, 322.
https://doi.org/10.3390/jcm11020322
AMA Style
Asleh R, Vucicevic D, Petterson TM, Kremers WK, Pereira NL, Daly RC, Edwards BS, Steidley DE, Scott RL, Kushwaha SS.
Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study. Journal of Clinical Medicine. 2022; 11(2):322.
https://doi.org/10.3390/jcm11020322
Chicago/Turabian Style
Asleh, Rabea, Darko Vucicevic, Tanya M. Petterson, Walter K. Kremers, Naveen L. Pereira, Richard C. Daly, Brooks S. Edwards, D. Eric Steidley, Robert L. Scott, and Sudhir S. Kushwaha.
2022. "Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study" Journal of Clinical Medicine 11, no. 2: 322.
https://doi.org/10.3390/jcm11020322
APA Style
Asleh, R., Vucicevic, D., Petterson, T. M., Kremers, W. K., Pereira, N. L., Daly, R. C., Edwards, B. S., Steidley, D. E., Scott, R. L., & Kushwaha, S. S.
(2022). Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study. Journal of Clinical Medicine, 11(2), 322.
https://doi.org/10.3390/jcm11020322
